Results 281 to 290 of about 74,157 (302)

Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis

Journal of Dermatological Treatment, 2022
Kevin Phan, Monisha Gupta
exaly  

Comparative efficacy and safety of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and network meta-analysis

Therapeutic Advances in Musculoskeletal Disease, 2021
Chenghua Weng, Leixi Xue, Zhichun Liu
exaly  

Janus Kinase (JAK) Inhibitors

2022
Courtney E. Heron, Lindsay C. Strowd, Steven R. Feldman   +2 more
openaire   +1 more source

Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases

Journal of Cellular Physiology, 2020
Arezoo Hosseini, Tohid Gharibi, Faroogh Marofi   +2 more
exaly  

<p>Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis</p>

ImmunoTargets and Therapy, 2020
Rhea Singh, Courtney E Heron, Rima I Ghamrawi   +2 more
exaly  

Janus Kinase Inhibitors and Risk of Venous Thromboembolism: A Systematic Review and Meta-analysis

Mayo Clinic Proceedings, 2021
Jawad Bilal, Irbaz bin Riaz, Syed Arsalan Ahmed Naqvi   +2 more
exaly  

Synthesis of a Janus Kinase Inhibitor

Synfacts, 2020
openaire   +1 more source

Janus kinase inhibitors in dermatology: A systematic review

Journal of the American Academy of Dermatology, 2017
Rony Shreberk-Hassidim, Yuval Ramot, Abraham Zlotogorski   +2 more
exaly  

Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)

Bioorganic and Medicinal Chemistry Letters, 2007
Adam Golebiowski
exaly  

Janus Kinase Inhibitors

2016
openaire   +1 more source